Showing results (91-100 of 198) with videos related to
Sort By:
Pageof 20
Archiv Der Pharmazie|July 31, 2022
Phenol-benzoxazolone bioisosteres of GluN2B-NMDA receptor antagonists: Unexpected rearrangement during reductive alkylation with phenylcyclohexanoneAlexander Markus, Julian A Schreiber, Gunnar Goerges, et al.Biochemical and Biophysical Research Communications|December 15, 2011
Activation of voltage gated K⁺ channel Kv1.5 by β-cateninCarlos Munoz, Roberta H Tóvolli, Mentor Sopjani, et al.European Journal of Medicinal Chemistry|September 16, 2018
Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201Julian A Schreiber, Sebastian L Müller, Stefanie E Westphälinger, et al.Biological Chemistry|October 10, 2022
Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepine-1,7-diol - starting point for PET tracer developmentMarvin Korff, Ruben Steigerwald, Elena Bechthold, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 31, 2024
Evaluation of SK-N-SH Cells as a Model for NMDA Receptor Induced ToxicityGunnar Goerges, Paul Disse, Stefan Peischard, et al.Chemmedchem|July 15, 2021
[2.2]Paracyclophane-Based TCN-201 Analogs as GluN2A-Selective NMDA Receptor AntagonistsRemya Rajan, Dirk Schepmann, Ruben Steigerwald, et al.FEBS Letters|April 23, 2013
Klotho sensitivity of the hERG channelCarlos Munoz, Tatsiana Pakladok, Ahmad Almilaji, et al.Pflugers Archiv : European Journal of Physiology|December 17, 2014
Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?Aytug K Kiper, Susanne Rinné, Caroline Rolfes, et al.Membranes|August 12, 2014
Auxiliary subunits: shepherding AMPA receptors to the plasma membraneSimon C Haering, Daniel Tapken, Steffen Pahl, et al.Nature Communications|October 13, 2016
KCNE1 induces fenestration in the Kv7.1/KCNE1 channel complex that allows for highly specific pharmacological targetingEva Wrobel, Ina Rothenberg, Christoph Krisp, et al.Pageof 20